Search results
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 1 day agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed up with the participants for...
Cancer breakthrough as scientists develop jab that could provide miracle cure
Daily Express· 6 days agoA revolutionary skin cancer vaccine being tested on British patients offers hope of a cure for the...
1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation
Motley Fool via Yahoo Finance· 2 days agoZoetis has reiterated that the drugs are safe and noted that theside effects amount to less than 1%...
3 Ultra-Yield Dividend Stocks Retirees Can Trust
247wallst.com· 2 days agoDividends are a major part of an investor’s complete return profile. By the same token, retirees don’t want to leave potential returns on the table,...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 1 day agoSHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer: NNVC ) (the "Company"),...